<DOC>
	<DOCNO>NCT00911742</DOCNO>
	<brief_summary>The main purpose study compare pharmacokinetic profile establish good control liberation test product ( Tramadol HCL OAD tablets 200 mg , Labopharm ) bioavailability relation commercialise reference ( Zytram® tablets 200 mg , Zambon ) , single dose administer .</brief_summary>
	<brief_title>Comparative Bioavailability Between Two Tramadol Formulations : Study Better Controlled Release New 200 mg Once A Day ( OAD ) Formulation Versus Zytram® 200 mg</brief_title>
	<detailed_description />
	<mesh_term>Tramadol</mesh_term>
	<criteria>Healthy subject either gender Age 18 45 year Body mass index 19 27kg/m2 Normal medical history Normal clinically significant physical examination finding Normal clinically significant finding analytical test Negative hepatitis B , hepatitis C HIV serology Negative drug abuse urine Negative pregnancy test females The subject understand accepts study procedures grant write his/her inform consent Did fulfill inclusion criterion Organic disorder underwent major surgery , within 90 day study screen Psychiatric history Alcohol drink intake great 30gr/day Cigarette smoking great 10 cigarettes/day Excessive consumption food beverage contain xanthine ( five unit coffee , tea cola per day ) Medical treatment within 30 day screen , and/or medication 7 day start study Participation clinical study donate blood within 90 day start study Antecedents gastric , hepatic , renal kind disorder could affect ADME ( absorption , distribution , metabolism excretion study drug ) Hepatitis B , hepatitis C HIV positive serology Pregnant breastfeeding Clinically relevant hypersensitivity ( particular drug ) Woman take oral contraceptive drug Incapable communicate cooperate investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>